Irving H, Turek I, Kettle C, Yaakob N
Int J Mol Sci. 2021; 22(21).
PMID: 34769340
PMC: 8584345.
DOI: 10.3390/ijms222111910.
Bonisch H, Fink K, Malinowska B, Molderings G, Schlicker E
Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(9):1829-1867.
PMID: 33991216
PMC: 8376721.
DOI: 10.1007/s00210-021-02083-5.
Koyama Y, Kondo M, Shimada S
Sci Rep. 2017; 7:42884.
PMID: 28276429
PMC: 5343592.
DOI: 10.1038/srep42884.
Wyskiel D, Andrade R
Hippocampus. 2016; 26(9):1107-14.
PMID: 27328460
PMC: 4996712.
DOI: 10.1002/hipo.22611.
Lemieux G, Keiser M, Sassano M, Laggner C, Mayer F, Bainton R
PLoS Biol. 2013; 11(11):e1001712.
PMID: 24260022
PMC: 3833878.
DOI: 10.1371/journal.pbio.1001712.
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests.
Bhatt S, Mahesh R, Devadoss T, Jindal A
Indian J Pharmacol. 2013; 45(4):348-53.
PMID: 24014909
PMC: 3757602.
DOI: 10.4103/0253-7613.115014.
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.
Newman A, Batis N, Grafton G, Caputo F, Brady C, Lambert J
Br J Pharmacol. 2013; 169(6):1228-38.
PMID: 23594147
PMC: 3831704.
DOI: 10.1111/bph.12213.
5-HT(3) receptors.
Lummis S
J Biol Chem. 2012; 287(48):40239-45.
PMID: 23038271
PMC: 3504740.
DOI: 10.1074/jbc.R112.406496.
Serotonin receptors in hippocampus.
Berumen L, Rodriguez A, Miledi R, Garcia-Alcocer G
ScientificWorldJournal. 2012; 2012:823493.
PMID: 22629209
PMC: 3353568.
DOI: 10.1100/2012/823493.
The chemical basis of pharmacology.
Keiser M, Irwin J, Shoichet B
Biochemistry. 2010; 49(48):10267-76.
PMID: 21058655
PMC: 2994275.
DOI: 10.1021/bi101540g.
NT79: A novel neurotensin analog with selective behavioral effects.
Boules M, Liang Y, Briody S, Miura T, Fauq I, Oliveros A
Brain Res. 2009; 1308:35-46.
PMID: 19874804
PMC: 2792000.
DOI: 10.1016/j.brainres.2009.10.050.
Preclinical and early clinical investigations related to monoaminergic pain modulation.
Bannister K, Bee L, Dickenson A
Neurotherapeutics. 2009; 6(4):703-12.
PMID: 19789074
PMC: 5084291.
DOI: 10.1016/j.nurt.2009.07.009.
[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
Bois A
Med Klin (Munich). 2009; 93 Suppl 1:3-17.
PMID: 19479418
DOI: 10.1007/BF03041988.
Genetically expressed transneuronal tracer reveals direct and indirect serotonergic descending control circuits.
Braz J, Basbaum A
J Comp Neurol. 2008; 507(6):1990-2003.
PMID: 18273889
PMC: 4947410.
DOI: 10.1002/cne.21665.
Development of an intestinal cell culture model to obtain smooth muscle cells and myenteric neurones.
Lobo S, Denyer M, Britland S, Javid F
J Anat. 2007; 211(6):819-29.
PMID: 17979953
PMC: 2375843.
DOI: 10.1111/j.1469-7580.2007.00820.x.
Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition.
Banerjee S, Akbar N, Moorhead J, Rennie J, Leather A, Cooper D
Int J Colorectal Dis. 2006; 22(6):643-9.
PMID: 17086395
DOI: 10.1007/s00384-006-0216-4.
5-HT3 receptors.
Thompson A, Lummis S
Curr Pharm Des. 2006; 12(28):3615-30.
PMID: 17073663
PMC: 2664614.
DOI: 10.2174/138161206778522029.
[5-HT3 receptor antagonist als analgetics in rheumatic diseases].
Muller W, Fiebich B, Stratz T
Z Rheumatol. 2006; 65(6):546, 548-52.
PMID: 16450149
DOI: 10.1007/s00393-005-0014-3.
Frequency-dependent modulation of retinogeniculate transmission by serotonin.
Seeburg D, Liu X, Chen C
J Neurosci. 2004; 24(48):10950-62.
PMID: 15574745
PMC: 6730221.
DOI: 10.1523/JNEUROSCI.3749-04.2004.
Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
Holohean A, Hackman J
Br J Pharmacol. 2004; 143(3):351-60.
PMID: 15339859
PMC: 1575347.
DOI: 10.1038/sj.bjp.0705935.